Evidence map›Paper›PMID 32253218›Full record

ArticleAntimicrobial agents and chemotherapy2020

MgrB Inactivation Is Responsible for Acquired Resistance to Colistin in Enterobacter hormaechei subsp.

Amel Mhaya, Dominique Bégu, Slim Tounsi, Corinne Arpin

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Colistin heteroresistance inAntimicrobial agents and chemotherapy · 2025
    Article
  2. Insertion sequences inFrontiers in microbiology · 2025
    Article
  3. Polymyxin resistance in Enterobacter cloacae complex in Brazil: phenotypic and molecular characterization.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  4. Article
  5. Article
  6. Genetic Diversity of Virulent Polymyxin-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Absence ofAntibiotics (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Amel MhayaLaboratoire de Microbiologie Fondamentale et Pathogénicité (MFP), Université de Bordeaux, CNRS UMR-5234, Bordeaux, France.
Dominique BéguLaboratoire de Microbiologie Fondamentale et Pathogénicité (MFP), Université de Bordeaux, CNRS UMR-5234, Bordeaux, France.
Slim TounsiLaboratoire des Biopesticides, Centre de Biotechnologie de Sfax, Sfax, Tunisia.
Corinne ArpinLaboratoire de Microbiologie Fondamentale et Pathogénicité (MFP), Université de Bordeaux, CNRS UMR-5234, Bordeaux, France corinne.arpin@u-bordeaux.fr.ORCID 0000-0001-5590-1752
Centre National de la Recherche Scientifique · FRCentre of Biotechnology of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant strains belonging to the

Indexed as

ColistinDrug Resistance, BacterialAnti-Bacterial AgentsBacterial ProteinsEnterobacterKlebsiella pneumoniaeMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial ProteinsColistincolistin resistanceEnterobacter cloacae complexEnterobacter hormaechei subsp. steigerwaltiiMgrBPhoPQ regulatory system

Identifiers

PMID32253218
PMCPMC7269514
OpenAlexW3014682556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.